Grifols signs deal to license Aradigm's Pulmaquin
May 21, 2013 at 02:47 AM EDT
MADRID, May 21 (Reuters) - Spanish drugmaker Grifols said on Tuesday it has signed an exclusive contract to license U.S. Aradigm Corporation's Pulmaquin compound and may take a stake in the California-based firm.
